Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Chatal

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, SaclayP Peltier, J P Dutin, J F Chatal, et al.
European Journal of Nuclear Medicine|January 1, 1992
Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), FranceP Peltier, K Wiharto, J P Dutin, et al.
International Journal of Cancer|May 1, 1994
Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combinationB M Imbert-Marcille, P Thédrez, C Saï-Maurel, et al.
Cancer Research|June 1, 1989
Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomasJ F Chatal, J C Saccavini, J F Gestin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastasesI Resche, J F Chatal, A Pecking, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1993
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune responseJ M Le Doussal, A Chetanneau, A Gruaz-Guyon, et al.
International Journal of Cancer|April 1, 1992
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluationM Bardiès, P Thedrez, J F Gestin, et al.
The New England Journal of Medicine|October 12, 1989
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysisH Sobol, S A Narod, Y Nakamura, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Immunoscintigraphy of recurrences of gynecologic carcinomasJ F Chatal, P Fumoleau, J C Saccavini, et al.
Cancer Research|November 1, 1983
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinomaJ P Mach, J F Chatal, J D Lumbroso, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Usefulness of imaging ovarian cancer recurrence with In-111-labeled monoclonal antibody (OC 125) specific for CA 125 antigen. The INSERM Research Network (Nantes, Rennes, Reims, Vuillejuif, SaclayP Peltier, J P Dutin, J F Chatal, et al.
European Journal of Nuclear Medicine|January 1, 1992
Correlative imaging study in the diagnosis of ovarian cancer recurrences. The INSERM Research Network (Nantes, Rennes, Reims, Villejuif, Saclay), FranceP Peltier, K Wiharto, J P Dutin, et al.
International Journal of Cancer|May 1, 1994
Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combinationB M Imbert-Marcille, P Thédrez, C Saï-Maurel, et al.
Cancer Research|June 1, 1989
Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomasJ F Chatal, J C Saccavini, J F Gestin, et al.
European Journal of Cancer (Oxford, England : 1990)|December 9, 1997
A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastasesI Resche, J F Chatal, A Pecking, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1993
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune responseJ M Le Doussal, A Chetanneau, A Gruaz-Guyon, et al.
International Journal of Cancer|April 1, 1992
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluationM Bardiès, P Thedrez, J F Gestin, et al.
The New England Journal of Medicine|October 12, 1989
Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysisH Sobol, S A Narod, Y Nakamura, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1987
Immunoscintigraphy of recurrences of gynecologic carcinomasJ F Chatal, P Fumoleau, J C Saccavini, et al.
Cancer Research|November 1, 1983
Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinomaJ P Mach, J F Chatal, J D Lumbroso, et al.
Pageof 15